Michael Poch

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 412 citations · Full text

Urology, Oncology, Genitourinary Cancer +2

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole et al. · Journal of the National Comprehensive Cancer Network · 2016 · 341 citations · Full text

Preclinical Therapeutics, Nccn Guidelines Insights, Population Health Sciences +18

Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer

Charles C. Peyton, Dominic H. Tang, Richard R. Reich et al. · JAMA Oncology · 2018 · 146 citations · Full text

Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

Pranav Sharma, Kamran Zargar‐Shoshtari, Jamie T. Caracciolo et al. · Urologic Oncology Seminars and Original Investigations · 2015 · 129 citations

Urology, Surgical Oncology, Genitourinary Cancer +6

Prostate Cancer Early Detection, Version 1.2014

Peter R. Carroll, J. Kellogg Parsons, Gerald L. Andriole et al. · Journal of the National Comprehensive Cancer Network · 2014 · 107 citations · Full text

Urology, Oncology, Health Policy +12